T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.81B |
| 2 |
XYZ
Block Inc
XYZ
|
+$1.46B |
| 3 |
Accenture
ACN
|
+$1.23B |
| 4 |
Gilead Sciences
GILD
|
+$1.15B |
| 5 |
Valero Energy
VLO
|
+$1.05B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.61B |
| 2 |
Meta Platforms (Facebook)
META
|
+$2.06B |
| 3 |
Tesla
TSLA
|
+$1.81B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.72B |
| 5 |
Amazon
AMZN
|
+$1.59B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.44% |
| 2 | Healthcare | 13.92% |
| 3 | Financials | 12.3% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Communication Services | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALEX
2201
DELISTED
Alexander & Baldwin
ALEX
| $548K | ﹤0.01% |
31,783
+2,809
| +10% | +$49.6K |
|
2202
Clover Health Investments
CLOV
$2.38B
| $548K | ﹤0.01% |
+152,500
| New | +$612K |
|
2203
Mobileye
MBLY
$7.57B
| $545K | ﹤0.01% |
37,802
+2,000
| +6% | +$32.7K |
|
2204
Theravance Biopharma
TBPH
$878M
| $544K | ﹤0.01% |
60,844
-3,951
| -6% | -$36.8K |
|
2205
ANI Pharmaceuticals
ANIP
$1.72B
| $542K | ﹤0.01% |
8,089
+801
| +11% | +$47.8K |
|
2206
Employers Holdings
EIG
$871M
| $542K | ﹤0.01% |
10,692
+1,131
| +12% | +$56.1K |
|
2207
Microvision
MVIS
$89.7M
| $541K | ﹤0.01% |
29,082
-1,040
| -3% | -$21.7K |
|
2208
Harrow
HROW
$1.46B
| $540K | ﹤0.01% |
20,300
+1,224
| +6% | +$36.6K |
|
|
ACH
2209
Accendra Health
ACH
$84.6M
| $539K | ﹤0.01% |
59,689
+2,473
| +4% | +$26.1K |
|
2210
Caleres
CAL
$461M
| $538K | ﹤0.01% |
31,174
+719
| +2% | +$12.9K |
|
2211
Standard Motor Products
SMP
$870M
| $538K | ﹤0.01% |
21,558
+802
| +4% | +$23.5K |
|
2212
Compass Diversified
CODI
$924M
| $536K | ﹤0.01% |
28,699
+2,254
| +9% | +$46.6K |
|
2213
HCI Group
HCI
$2.32B
| $535K | ﹤0.01% |
3,579
+364
| +11% | +$46.2K |
|
2214
Koppers
KOP
$874M
| $535K | ﹤0.01% |
19,081
+659
| +4% | +$19.8K |
|
2215
Clearwater Paper
CLW
$354M
| $529K | ﹤0.01% |
20,849
+1,807
| +9% | +$50.4K |
|
|
XRN
2216
Chiron Real Estate Inc
XRN
$484M
| $529K | ﹤0.01% |
12,088
-33,676
| -74% | -$1.39M |
|
2217
B&G Foods
BGS
$299M
| $528K | ﹤0.01% |
76,834
+4,894
| +7% | +$32.7K |
|
2218
Gray Television
GTN
$520M
| $528K | ﹤0.01% |
122,077
+5,079
| +4% | +$20K |
|
2219
Oxford Industries
OXM
$542M
| $528K | ﹤0.01% |
8,983
+708
| +9% | +$50.9K |
|
|
TRST
2220
Trustco Bank Corp NY
TRST
$971M
| $528K | ﹤0.01% |
17,319
+1,175
| +7% | +$37.5K |
|
2221
Shore Bancshares
SHBI
$799M
| $527K | ﹤0.01% |
38,919
+1,173
| +3% | +$17.7K |
|
2222
BrightView Holdings
BV
$1.08B
| $524K | ﹤0.01% |
40,784
+2,794
| +7% | +$40K |
|
2223
CareDx
CDNA
$2.45B
| $523K | ﹤0.01% |
29,419
+2,303
| +8% | +$49.6K |
|
2224
Buckle
BKE
$2.31B
| $521K | ﹤0.01% |
13,588
+1,335
| +11% | +$57.8K |
|
2225
Sprinklr
CXM
$1.65B
| $518K | ﹤0.01% |
62,030
+5,060
| +9% | +$44.3K |
|
Similar funds
T. Rowe Price Associates's Q1 2025 Portfolio in Review
As of Q1 2025, T. Rowe Price Associates held 3,109 positions worth $812B, down 6.4% from $867B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q1 2025 filing shows 91 new, 2,002 increased, 738 reduced and 70 closed positions. Its largest new stake was T. Rowe Price Value ETF: 8,943,567 shares worth $283M. The largest sale was NVIDIA, an estimated $4.61B.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 33% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q1 2025 buy was T. Rowe Price Value ETF: 8,943,567 shares worth $283M.
- T. Rowe Price Associates added most to Broadcom in Q1 2025, an estimated $3.81B increase.
- T. Rowe Price Associates's biggest Q1 2025 reduction was NVIDIA, cutting an estimated $4.61B.
- T. Rowe Price Associates fully exited Summit Materials, Inc. Class A Common Stock in Q1 2025, selling an estimated $271M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $812B portfolio in Q1 2025.
- T. Rowe Price Associates opened 91 new positions and closed 70 in Q1 2025.
- T. Rowe Price Associates's portfolio value fell 6.4% quarter-over-quarter to $812B.
Based on T. Rowe Price Associates's 13F filing for Q1 2025, filed 14 May 2025.